日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genetically engineered ErbB2 overexpression sensitizes organoid-derived tumors to checkpoint inhibition in a syngeneic model of gastric cancer.

在同源胃癌模型中,基因工程改造的 ErbB2 过表达可使类器官衍生的肿瘤对检查点抑制剂更加敏感。

He Jiazhuo, Kirsche Lydia, Nascakova Zuzana, Manfredi Francesco, Magnani Chiara F, Papa Giovanni, Azizi Flora, Leary Peter, Müller Anne

Integrative multi-omic analysis identified ERBB2 mutations and senescence-driven immune suppression as dual therapeutic targets in LAR triple-negative breast cancer

整合多组学分析发现,ERBB2突变和衰老驱动的免疫抑制是LAR三阴性乳腺癌的双重治疗靶点。

Zhao, Yaxin; Wang, Han; Wang, Ying; Jiang, Yizhou; Hu, Xin; Shao, Zhiming

Pan-cancer multi-omic ERBB2-HER2 characterization using next-generation sequencing and quantitative proteomics

利用新一代测序和定量蛋白质组学进行泛癌多组学ERBB2-HER2表征

Hunt, Allison L; Randall, Jamie; Ogata, Jonathan D; Johnston, Laura; Swain, Whitney; Melvin, Savannah; Sharma, Meenakshi; Calvert, Valerie; Maxwell, G Larry; Bateman, Nicholas W; Petricoin, Emanuel F; Conrads, Thomas P; Cannon, Timothy L

SLC7A5-ERBB2 axis drives olaparib resistance via de novo lipid synthesis in ovarian cancer.

SLC7A5-ERBB2 轴通过卵巢癌中从头合成脂质驱动奥拉帕尼耐药性。

Survival outcomes of ERBB2-amplified metastatic colorectal cancer treated with first-line chemotherapy

ERBB2扩增转移性结直肠癌一线化疗的生存结果

Matsubara, Yuki; Bando, Hideaki; Nakamura, Yoshiaki; Misumi, Toshihiro; Ng, Dionne; Tajima, Eri; Pittell, Harlan; Ohtsu, Atsushi; Yoshino, Takayuki

ERBB2 mutations promote recurrence and metastasis in non-muscle-invasive bladder cancer via HIF-1 phosphorylation: Insights from whole exome sequencing

ERBB2突变通过HIF-1磷酸化促进非肌层浸润性膀胱癌的复发和转移:来自全外显子组测序的启示

Xu Wang,Long Jin,Xinlin Zou,Ankang Zhu,Mingyu Li,Haitao Fan

Non-HLA Risk Loci ERBB3/IKZF4 and ERBB2/IKZF3/GSDMB/ORMDL3 Interact to Influence Progression of Autoimmunity in Relatives of T1D Patients

非HLA风险位点ERBB3/IKZF4和ERBB2/IKZF3/GSDMB/ORMDL3相互作用影响1型糖尿病患者亲属自身免疫性疾病的进展

Mertens, Ina M; Keymeulen, Bart; Gorus, Frans K; Van De Casteele, Mark

Molecular insights into HER2/ERBB2 amplification and carcinogenesis in gallbladder cancer associated with pancreaticobiliary maljunction

胰胆管汇合异常相关胆囊癌中HER2/ERBB2扩增和癌变的分子机制研究

Zhu, Ming; Douchi, Daisuke; Murakami, Keigo; Itoh, Taito; Migita, Shusuke; Rikiyama, Naoki; Hayashi, Shuichiro; Kokumai, Takashi; Sato, Hideaki; Yoshimachi, Shingo; Kusaka, Akiko; Shimura, Mitsuhiro; Nakayama, Shun; Aoki, Shuichi; Iseki, Masahiro; Miura, Takayuki; Maeda, Shimpei; Ishida, Masaharu; Ohtsuka, Hideo; Mizuma, Masamichi; Nakagawa, Kei; Masamune, Atsushi; Furukawa, Toru; Unno, Michiaki

Correction: Molecular insights into HER2/ERBB2 amplification and carcinogenesis in gallbladder cancer associated with pancreaticobiliary maljunction

更正:胰胆管汇合异常相关胆囊癌中 HER2/ERBB2 扩增和癌变的分子机制研究

Zhu, Ming; Douchi, Daisuke; Murakami, Keigo; Itoh, Taito; Migita, Shusuke; Rikiyama, Naoki; Hayashi, Shuichiro; Kokumai, Takashi; Sato, Hideaki; Yoshimachi, Shingo; Kusaka, Akiko; Shimura, Mitsuhiro; Nakayama, Shun; Aoki, Shuichi; Iseki, Masahiro; Miura, Takayuki; Maeda, Shimpei; Ishida, Masaharu; Ohtsuka, Hideo; Mizuma, Masamichi; Nakagawa, Kei; Masamune, Atsushi; Furukawa, Toru; Unno, Michiaki

Correction to: Real-world characteristics and outcomes of ERBB2-mutant NSCLC in Latin American patients (CLICaP)

更正:拉丁美洲患者中 ERBB2 突变型非小细胞肺癌的真实世界特征和结果 (CLICaP)